Albendazole, marketed as Albenza, Eskazole, Zentel, Andazol and Alworm, is a member of thebenzimidazole compounds used as a drug indicated for the treatment of a variety of worm infestations. Although this use is widespread in the United States, the U.S. Food and Drug Administration (FDA) has not approved albendazole for this indication. It is marketed by Amedra Pharmaceuticals. Albendazole was first discovered at the SmithKline Animal Health Laboratories in 1972. It is a broad spectrum anthelmintic, effective against: roundworms, tapeworms, and flukes of domestic animals and humans.
Main usesIt is effective first line of treatment against:
Flatworms Flukes/trematodes FasciolosisTapeworm/cestodes CysticercosisEchinococcosisNematodes Enterobiasis (pinworm infection)Trichuriasis (whipworm infection)AscariasisHookwormCutaneous larva migrans (caused by Ancylostoma)FilariasisSpecifications:
Item Standard Test Result
Appearance White crystalline powder Pass
Identification Positive reaction Pass
Melting 206-212 207.2-210.2
Related Substances ≤0.5% Pass
Drying ≤0.5% 0.42%
Residue on Ignition≤0.2% 0.15%
Fineness ≤10mesh pass
Assay(HPLC) 98.0%-102.0% 99.60%
INSPECTION RESULT COMPLY WITH THE USP27
Albendazole CAS 54965-21-8